Min Seok Kim
Min Seok Kim has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Hyejin Park
RM 101-1702 ADLi Institute, AZothBio. Inc., 109 Mapo-daero, Mapo-gu, Seoul 04146, Republic of Korea
1 shared publication - Jae-Min Shin
AzothBio, Rm. DA724 Hyundai Knowledge Industry Center, Hanam-si, Republic of Korea
1 shared publication - Jung-Hyun Park
Department of Molecular Medicine, Ewha Womans University College of Medicine, Gangseo-gu, Seoul, South Korea
1 shared publication - Kwangmin Cho
RM D-724 Hyundai Knowledge Industry Center, AZothBio. Inc., 520 Misa-daero, Hanam-si 12927, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 13 March 2023
- Published by MDPI AG in Biomolecules
- Vol. 13 (3) , 522
In Silico Screening and Optimization of Cell-Penetrating Peptides Using Deep Learning Methods
Cell-penetrating peptides (CPPs) have great potential to deliver bioactive agents into cells. Although there have been many recent advances in CPP-related research, it is still important to develop more efficient CPPs. The development of CPPs by in silico methods is a very useful addition to experimental methods, but in many cases it can lead to a large number of false-positive results. In this study, we developed a deep-learning-based CPP prediction method, AiCPP, to develop novel CPPs. AiCPP uses a large number of peptide sequences derived from human-reference proteins as a negative set to reduce false-positive predictions and adopts a method to learn small-length peptide sequence motifs that may have CPP tendencies. Using AiCPP, we found that short peptide sequences derived from amyloid precursor proteins are efficient new CPPs, and experimentally confirmed that these CPP sequences can be further optimized.
- 13 March 2023
- Published by MDPI AG in Biomolecules
- Vol. 13 (3) , 522
Open AccessIn Silico Screening and Optimization of Cell-Penetrating Peptides Using Deep Learning Methods
Cell-penetrating peptides (CPPs) have great potential to deliver bioactive agents into cells. Although there have been many recent advances in CPP-related research, it is still important to develop more efficient CPPs. The development of CPPs by in silico methods is a very useful addition to experimental methods, but in many cases it can lead to a large number of false-positive results. In this study, we developed a deep-learning-based CPP prediction method, AiCPP, to develop novel CPPs. AiCPP uses a large number of peptide sequences derived from human-reference proteins as a negative set to reduce false-positive predictions and adopts a method to learn small-length peptide sequence motifs that may have CPP tendencies. Using AiCPP, we found that short peptide sequences derived from amyloid precursor proteins are efficient new CPPs, and experimentally confirmed that these CPP sequences can be further optimized.